4//SEC Filing
Espinoza Octavio 4
Accession 0002001011-26-000003
CIK 0000886163other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:21 PM ET
Size
4.7 KB
Accession
0002001011-26-000003
Insider Transaction Report
Form 4
Espinoza Octavio
Chief Financial Officer
Transactions
- Other
Common Stock
2025-12-31$95.68/sh+8$765→ 28,575 total
Footnotes (1)
- [F1]These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001905248
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:21 PM ET
- Size
- 4.7 KB